Hylenex Recombinant

Active Ingredient(s): Hyaluronidase Recombinant Human
FDA Approved: * December 2, 2005
Pharm Company: * HALOZYME THERAP
Category: Medical Device

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971, into three distinct groups, a scheme based on the enzyme reaction products.[1] The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.[2] In humans, there are five functional hyaluronidases: HYAL1, HYAL2, HYAL3, HYAL4 and HYAL5 (also known a... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hylenex Recombinant 150 [usp'u]/Ml Subcutaneous Injection, Solution
NDC: 18657-102
Labeler:
Halozyme, Inc.
Hylenex Recombinant 150 [usp'u]/Ml Subcutaneous Injection, Solution
NDC: 18657-117
Labeler:
Halozyme, Inc.
Hylenex Recombinant 150 [Usp'u]/Ml Subcutaneous Injection, Solution
NDC: 50090-4534
Labeler:
A-s Medication Solutions
Hylenex Recombinant 150 [usp'u]/Ml Subcutaneous Injection, Solution
NDC: 60977-319
Labeler:
Baxter Healthcare Corporation

Related Brands

Drugs with the same active ingredients